| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.6M | +2078.4% | — |
| R&D Expense | $2.9M | -20.4% | +31.2% |
| SG&A Expense | $2.6M | -12.1% | +15.2% |
| Operating Income | -$2.4M | +62.1% | +45.3% |
| Net Income | -$2.1M | +65.3% | +47.4% |
| EPS (Basic) | -$0.13 | +63.9% | +50.0% |
| EPS (Diluted) | -$0.13 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $28.1M | -5.5% | -9.4% |
| Current Assets | $32.0M | -4.2% | -9.8% |
| Total Assets | $32.0M | -4.2% | -9.9% |
| Current Liabilities | $3.7M | -18.5% | +58.1% |
| Total Liabilities | $4.8M | -7.5% | +34.4% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.7M | — | — |
| Investing Cash Flow | -$516K | — | — |
| Financing Cash Flow | $38K | — | — |
| +63.9% |
| +50.0% |
| $27.3M |
| -3.6% |
| -14.8% |